Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pathway Medical Technologies, a manufacturer of medical devices for the treatment of arterial disease, has received the FDA 510(k) clearance to market the Jetstream G2 specifically for use in breaking apart and removing thrombus from the upper and lower extremity peripheral arteries.
Subscribe to our email newsletter
According to the company, the Jetstream G2 is a peripheral atherectomy catheter designed to remove all kinds of artery-clogging plaque in the lower limbs of patients. This minimally invasive solution clears blockages in the peripheral vasculature, restores blood flow and effectively treats peripheral arterial disease (PAD).
Jetstream G2 is capable of treating the entire spectrum of disease found in patients suffering from PAD, including hard and soft plaque, calcium, fibrotic lesions and thrombus, with consistent results, the company said.
Paul Buckman, president and CEO of Pathway Medical Technologies, said: “The new thrombectomy indication for Jetstream G2 helps us deliver on our commitment to meet the needs of PAD sufferers with innovative technology and continually bring value to our physician customers across the country.”